Wilson et al., 1987 - Google Patents
Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroidsWilson et al., 1987
View PDF- Document ID
- 16197682562725461679
- Author
- Wilson K
- Lord E
- Publication year
- Publication venue
- British journal of cancer
External Links
Snippet
The development of a serum-free, low-protein culture medium has allowed the detection of tumour-specific cytolytic cells in EMT6 immunized mice bearing EMT6 multicellular tumour spheroids. Spheroid associated (SAC) and peritoneal (PC) effector cells were specific to …
- 230000001461 cytolytic 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rosenstein et al. | Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2 | |
Inaba et al. | Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. | |
Lee et al. | Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. | |
Ortaldo et al. | Cytotoxic reactivity of human lymphocytes cultured in vitro | |
Ko et al. | Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen-and antigen-activated T cells. | |
Cozzolino et al. | Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. | |
Buessow et al. | Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice | |
Dennert et al. | Continuously proliferating T killer cells specific for H-2b targets: selection and characterization | |
Roman et al. | Leukemia in AKR mice. I. Effects of leukemic cells on antibody-forming potential of syngeneic and allogeneic normal cells. | |
Baxevanis et al. | Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin α1 enhances while thymosin β4 suppresses the human autologous and allogeneic mixed lymphocyte reaction | |
Koide et al. | Augmentation of Human Natural Cell-Mediated Cytotoxicity by a Soluble Factor: I. Production of N-Cell-Activating Factor (NAF) | |
Wilson et al. | Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroids | |
Wolf et al. | Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma | |
US20030190306A1 (en) | HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula | |
Rabinowich et al. | Clonal analysis of human tumor infiltrating lymphocytes reactive with autologous tumor cells: different target cell specificities of NK-like and cytotoxic T-cell clones | |
Bonavida | The SJL/J spontaneous reticulum cell sarcoma: new insights in the fields of neoantigens, host-tumor interactions, and regulation of tumor growth | |
Merluzzi et al. | Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice. | |
Blazar et al. | In Situ Lymphoid Cells of Mouse Mammary Tumors: III. In Vitro Stimulation of Tumor Cell Survival by Lymphoid Cells Separated from Mammary Tumors | |
Lotzová | Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy | |
Klempau et al. | T-lymphocyte and B-lymphocyte dichotomy in anuran amphibians: III. Assessment and identification of inducible killer T-lymphocytes (IKTL) and spontaneous killer T-lymphocytes (SKTL) | |
Click | IMMUNE RESPONSES IN VITRO: IX. Absence of the Mixed Leukocyte Stimulatory, M-Locus Product from Thymus Cells | |
EP0257962A2 (en) | Method for treatment of peripheral blood to improve lymphokine activated killer immunotherapy | |
Kooistra et al. | Killer cells of feline leukemia virus-and feline sarcoma virus-infected transformed cells: the role of NK, ADCC, and in vitro generated cytotoxic cells | |
Ortaldo et al. | Responses of Human Large Granular Lymphocytes and Classical T‐Cells in Culture to Allogeneic Cells, Lectins, and Soluble Antigen | |
O'Keefe et al. | Variation in accessory cell requirements in human mixed lymphocyte response to leukaemic cell lines. |